J. E. Fischer

Assessing the translatability of In vivo cardiotoxicity mechanisms to In vitro models using causal reasoning

Ahmed Enayetallah, D. Ziemek, M. Pletcher, 2013, BMC Pharmacology and Toxicology.

Comparing 2-nt 3' overhangs against blunt-ended siRNAs: a systems biology based study

Chaoyang Zhang, Preetam Ghosh, Kalyan Basu, 2009, BMC Genomics.

Molecular Characterization of Novel and Selective Peroxisome Proliferator-Activated Receptor (cid:1) Agonists with Robust Hypolipidemic Activity in Vivo □ S

P. Zagouras, O. Francone, L. Royer, 2009 .

EVIDENCE FOR A FALSE NEUROCHEMICAL TRANSMITTER AS A MECHANISM FOR THE HYPOTENSIVE EFFECT OF MONOAMINE OXIDASE INHIBITORS.

I. Kopin, J. Musacchio, J. E. Fischer, 1964, Proceedings of the National Academy of Sciences of the United States of America.

Transcriptomic analysis of genetically defined autism candidate genes reveals common mechanisms of action

D. Stephenson, M. Pletcher, M. Gosink, 2013, Molecular Autism.

Molecular Characterization of Novel and Selective Peroxisome Proliferator-Activated Receptor α Agonists with Robust Hypolipidemic Activity in Vivo

P. Zagouras, O. Francone, L. Royer, 2009, Molecular Pharmacology.

Analysis of the interaction of naltrexone with eating following adrenergic and cholinergic stimulation of the hypothalamus

W. Chance, J. E. Fischer, J. Finkelstein, 1982, Neuropharmacology.

Kinetic analysis of genomewide gene expression reveals molecule circuitries that control T cell activation and Th1/2 differentiation.

R. Flavell, B. Lu, P. Zagouras, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Molecular Characterization of Novel and Selective Peroxisome Proliferator-Activated Receptor α Agonists with Robust Hypolipidemic Activity in Vivo

P. Zagouras, O. Francone, L. Royer, 2009, Molecular Pharmacology.

False Adrenergic Transmitter Release from the Isolated Cat Heart

I. Kopin, V. Weise, J. E. Fischer, 1968, The American journal of the medical sciences.